Immune Tolerance Dysfunction in Pregnancy due to Ambient Air Pollution Exposure

由于环境空气污染暴露而导致妊娠期免疫耐受功能障碍

基本信息

  • 批准号:
    10225619
  • 负责人:
  • 金额:
    $ 37.68万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-08-01 至 2025-05-31
  • 项目状态:
    未结题

项目摘要

ABSTRACT Exposure of pregnant women to environmental pollution and toxicants significantly increase risks to mother’s health after birth. Specifically, pollution is association with increased rates of maternal mortality and morbidities of infertility, spontaneous preterm birth, asthma, allergy, cardiovascular disease, autoimmune disease, as well as pre-eclampsia and eclampsia. The maternal immune system plays a critical role in establishing, maintaining, and completing a healthy pregnancy and the constant state of growth and proliferation of this system makes it sensitive to pollutants. Insufficient immunological adaption in pregnancy is associated with many diseases during and after pregnancy. Although epidemiologic studies point to links between specific environmental toxicants and adverse outcomes in mothers, to date, there have been little to no studies of the effects of air pollution toxicants on pregnant mothers’ immune health during and after pregnancy. We hypothesize that chronic exposure to ambient air pollution, specifically fine particulate matter PM2.5, will increase immune dysregulation in pregnant women during, and in short- (immediate postpartum, 1 yr after birth) and long-term periods (3 years after birth) after pregnancy. Using previously collected biosamples from pregnant (n=200) and nonpregnant (n=200) women exposed to high and low levels of pollution (chiefly PM2.5), we will 1) test whether immune cell subsets are different in identity and function in pregnant vs. non pregnant women exposed to high vs. low pollution; 2) identify and validate epigenetic molecular mechanisms driving immune dysfunction in pregnancy vs no pregnancy with high vs low PM2.5 exposure using methylation, EpiTOF, ATAC-seq, and histone ChIP-seq; and 3) map T cell receptor diversity to immune dysfunction in pregnancy vs non pregnancy with high vs. low PM2.5 exposure. If the aims are met, this study will allow us to identify the drivers of immune dysfunction and potential modifiable factors for the future. We will explore how these immune findings are associated with the outcomes of diseases for which we have previously collected metadata: asthma, infections, allergy, pre-eclampsia, eclampsia, preterm birth, and autoimmune disease. Most importantly, our findings will likely impact public health and policy decisions surrounding air pollution exposure in a highly vulnerable population such as pregnant women.
摘要 孕妇暴露于环境污染和有毒物质会大大增加母亲的风险。 出生后的健康具体而言,污染与产妇死亡率和发病率的增加有关 不孕症,自发性早产,哮喘,过敏,心血管疾病,自身免疫性疾病,以及 先兆子痫和子痫母体免疫系统在建立, 保持,并完成健康的怀孕和不断的增长和增殖的状态, 系统对污染物敏感。妊娠期免疫适应不足与 怀孕期间和怀孕后的许多疾病。尽管流行病学研究指出, 环境毒物和母亲的不良后果,迄今为止,很少或没有研究, 大气污染毒物对孕妇孕期及产后免疫健康的影响我们 假设长期暴露于环境空气污染,特别是细颗粒物PM2.5, 在怀孕期间和短期内(产后即刻,产后1年)增加孕妇的免疫失调 出生后)和怀孕后的长期(出生后3年)。使用之前收集的生物样本, 孕妇(n=200)和非孕妇(n=200)暴露于高水平和低水平污染(主要是PM2.5), 我们将1)测试免疫细胞亚群在妊娠与非妊娠中的身份和功能是否不同 暴露于高污染与低污染的妇女; 2)确定和验证表观遗传分子机制, 使用甲基化,在高与低PM2.5暴露下怀孕与未怀孕的免疫功能障碍, EpiTOF、ATAC-seq和组蛋白ChIP-seq;和3)将T细胞受体多样性映射到免疫功能障碍, 怀孕与非怀孕,高与低PM2.5暴露。如果目标实现,这项研究将使我们能够 确定免疫功能障碍的驱动因素和未来潜在的可改变因素。我们将探讨如何 这些免疫发现与我们先前收集的疾病结果有关 元数据:哮喘、感染、过敏、先兆子痫、子痫、早产和自身免疫性疾病。最 重要的是,我们的发现可能会影响公众健康和有关空气污染暴露的政策决定 尤其是孕妇等高危人群。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kari C. Nadeau其他文献

Baseline epitope-specific IgE profiles are predictive of sustained unresponsiveness or high threshold 1-year post oral immunotherapy in the POISED trial
在“口服免疫治疗疗效和安全性评估(POISED)”试验中,基线表位特异性免疫球蛋白E(IgE)谱可预测口服免疫治疗1年后持续无反应或高阈值反应情况。
  • DOI:
    10.1016/j.jaci.2024.10.017
  • 发表时间:
    2025-03-01
  • 期刊:
  • 影响因子:
    11.200
  • 作者:
    Maria Suprun;Ashley Sang Eun Lee;Robert Getts;Simon Peck;Sayantani B. Sindher;Kari C. Nadeau;R. Sharon Chinthrajah;Stephen J. Galli;Hugh A. Sampson
  • 通讯作者:
    Hugh A. Sampson
Identification , Characterization , and initial epitope mapping of a pine nut allergen
松子过敏原的鉴定、表征和初始表位作图
  • DOI:
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yuzhu Zhang;Wen;Yuting Fan;Jiang Yi;S. Lyu;Kari C. Nadeau;Tara H. McHugh
  • 通讯作者:
    Tara H. McHugh
Novel dosing strategy of omalizumab during multi-allergen oral-immunotherapy
  • DOI:
    10.1016/j.waojou.2020.100415
  • 发表时间:
    2020-08-01
  • 期刊:
  • 影响因子:
  • 作者:
    Sayantani B. Sindher;Andrew Long;Natasha Purington;Divya Kumar;Stacey Skura;Margaret A. Woch;Tiffany Tan;Andres Alvarez;R. Sharon Chinthrajah;Maria Garcia-Lloret;Kari C. Nadeau
  • 通讯作者:
    Kari C. Nadeau
How does global warming contribute to disorders originating from an impaired epithelial barrier?
全球变暖如何导致源自上皮屏障受损的疾病?
  • DOI:
    10.1016/j.anai.2023.08.010
  • 发表时间:
    2023-12-01
  • 期刊:
  • 影响因子:
    4.700
  • 作者:
    Cevdet Ozdemir;Umut Can Kucuksezer;Ismail Ogulur;Yagiz Pat;Duygu Yazici;Ioana Agache;Marek Jutel;Kari C. Nadeau;Mübeccel Akdis;Cezmi A. Akdis
  • 通讯作者:
    Cezmi A. Akdis
Decreased Migratory Potential of Treg Cells in CRSwNP
  • DOI:
    10.1016/j.otohns.2010.06.707
  • 发表时间:
    2010-08-01
  • 期刊:
  • 影响因子:
  • 作者:
    Amanda Munoz;Kari C. Nadeau;Peter H. Hwang
  • 通讯作者:
    Peter H. Hwang

Kari C. Nadeau的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kari C. Nadeau', 18)}}的其他基金

Clinical Core
临床核心
  • 批准号:
    10584556
  • 财政年份:
    2022
  • 资助金额:
    $ 37.68万
  • 项目类别:
Clinical Core
临床核心
  • 批准号:
    10419277
  • 财政年份:
    2022
  • 资助金额:
    $ 37.68万
  • 项目类别:
Air pollution disrupts Inflammasome Regulation in HEart And Lung Total Health (AIRHEALTH)
空气污染扰乱心肺总体健康中的炎症小体调节 (AIRHEALTH)
  • 批准号:
    10460326
  • 财政年份:
    2021
  • 资助金额:
    $ 37.68万
  • 项目类别:
Administrative Core for the Air pollution disrupts Inflammasome Regulation in HEart And Lung Total Health (AIRHEALTH) Study
空气污染的管理核心扰乱心肺总体健康(AIRHEALTH)研究中的炎症小体调节
  • 批准号:
    10269331
  • 财政年份:
    2021
  • 资助金额:
    $ 37.68万
  • 项目类别:
Clinical Core
临床核心
  • 批准号:
    10491675
  • 财政年份:
    2021
  • 资助金额:
    $ 37.68万
  • 项目类别:
Clinical Core
临床核心
  • 批准号:
    10687221
  • 财政年份:
    2021
  • 资助金额:
    $ 37.68万
  • 项目类别:
Administrative Core for the Air pollution disrupts Inflammasome Regulation in HEart And Lung Total Health (AIRHEALTH) Study
空气污染的管理核心扰乱心肺总体健康(AIRHEALTH)研究中的炎症小体调节
  • 批准号:
    10684157
  • 财政年份:
    2021
  • 资助金额:
    $ 37.68万
  • 项目类别:
Air pollution disrupts Inflammasome Regulation in HEart And Lung Total Health (AIRHEALTH)
空气污染扰乱心肺总体健康中的炎症小体调节 (AIRHEALTH)
  • 批准号:
    10684155
  • 财政年份:
    2021
  • 资助金额:
    $ 37.68万
  • 项目类别:
Interaction between genetic, lifestyle and environmental factors determining circulating angiotensin-converting enzyme 2 protein expression: implications for the severity of COVID-19 infection
遗传、生活方式和环境因素之间的相互作用决定循环血管紧张素转换酶 2 蛋白表达:对 COVID-19 感染严重程度的影响
  • 批准号:
    10228516
  • 财政年份:
    2021
  • 资助金额:
    $ 37.68万
  • 项目类别:
Project 1 for the Air pollution disrupts Inflammasome Regulation in HEart And Lung Total Health (AIRHEALTH) Study
空气污染扰乱心肺总体健康 (AIRHEALTH) 研究中的炎症小体调节项目 1
  • 批准号:
    10684167
  • 财政年份:
    2021
  • 资助金额:
    $ 37.68万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 37.68万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.68万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 37.68万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.68万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 37.68万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.68万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 37.68万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 37.68万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 37.68万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.68万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了